A federal bankruptcy judge stated on Friday his intention to approve a sweeping 74 billion restructuring plan for Purdue Pharma This plan addresses numerous claims alleging the pharmaceutical company played a significant role in fueling the US opioid epidemic through sales of addictive painkillers such as OxyContin
